Detalhe da pesquisa
1.
Combination of T cell-redirecting strategies with a bispecific antibody blocking TGF-ß and PD-L1 enhances antitumor responses.
Oncoimmunology
; 13(1): 2338558, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38623463
2.
Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo.
Sci Transl Med
; 16(734): eadg7962, 2024 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38354229
3.
Bi- and trispecific immune cell engagers for immunotherapy of hematological malignancies.
J Hematol Oncol
; 16(1): 83, 2023 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37501154
4.
When three is not a crowd: trispecific antibodies for enhanced cancer immunotherapy.
Theranostics
; 13(3): 1028-1041, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36793863
5.
A PD-L1/EGFR bispecific antibody combines immune checkpoint blockade and direct anti-cancer action for an enhanced anti-tumor response.
Oncoimmunology
; 12(1): 2205336, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37114242
6.
Trispecific T-cell engagers for dual tumor-targeting of colorectal cancer.
Oncoimmunology
; 11(1): 2034355, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35154908
7.
Tumor targeted 4-1BB agonist antibody-albumin fusions with high affinity to FcRn induce anti-tumor immunity without toxicity.
iScience
; 25(9): 104958, 2022 Sep 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36072551
8.
Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell Engagers.
Cancer Immunol Res
; 10(4): 498-511, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35362043
9.
An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity.
Clin Cancer Res
; 27(11): 3167-3177, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33785484
10.
TGF-ß-induced IGFBP-3 is a key paracrine factor from activated pericytes that promotes colorectal cancer cell migration and invasion.
Mol Oncol
; 14(10): 2609-2628, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32767843
11.
Case Report: An EGFR-Targeted 4-1BB-agonistic Trimerbody Does Not Induce Hepatotoxicity in Transgenic Mice With Liver Expression of Human EGFR.
Front Immunol
; 11: 614363, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33488625
12.
Anti-tumoral potential of a human granulysin-based, CEA-targeted cytolytic immunotoxin.
Oncoimmunology
; 8(11): 1641392, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31646080
13.
A tumor-targeted trimeric 4-1BB-agonistic antibody induces potent anti-tumor immunity without systemic toxicity.
Nat Commun
; 9(1): 4809, 2018 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30442944